DNALYTICS
Company Snapshot
Founded: 2012
Entity Type: Private
Region: Belgium
Headquarter: Louvain-la-Neuve, Wallonia, Belgium
Key Geographics: Belgium
Corporate Address: Centre Monnet – Avenue Jean Monnet, 1348 Louvain-la-Neuve, Wallonia Belgium Tel. www.dnalytics.com
Company Overview
DNAlytics, founded in 2012 as a spinoff of UCLouvain, is developing and commercializing assays for screening and patient monitoring in cancer and rheumatology.
The company’s lead liquid biopsy product is ColonoKit, a noninvasive colorectal cancer screening test in joint development with VIB. The test is based on a 23-gene expression signature in tumor educated circulating monocytes that was identified by VIB. The test can be used before colonoscopy to detect the presence of colorectal cancer.
DNALYTICS In News
Company's Business Segments
- Healthcare Services : Data Mining, Statistics, Personalized Medicine, Clinical Trials, Diagnostic, Prognostic, Theranostic, Biomarkers
Applications/End User Industries
- Healthcare
- Hospitals
- Diagnostics
- Theranostics